Filing Details
- Accession Number:
- 0000899243-19-029172
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-13 17:46:42
- Reporting Period:
- 2019-12-11
- Accepted Time:
- 2019-12-13 17:46:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1629137 | Global Blood Therapeutics Inc. | GBT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1574286 | A. Philip Pizzo | C/O Global Blood Therapeutics, Inc. 171 Oyster Point Blvd., Suite 300 South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-11 | 15,000 | $18.85 | 15,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-12-11 | 15,000 | $28.45 | 30,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-11 | 27,868 | $76.52 | 2,132 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-11 | 2,132 | $77.25 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-11 | 15,000 | $0.00 | 15,000 | $18.85 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-11 | 15,000 | $0.00 | 15,000 | $28.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-06-15 | No | 4 | M | Direct | |
| 0 | 2027-06-19 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sale price of the shares sold from $76.12 to $77.11 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in footnotes 1 and 2.
- Represents the weighted average sale price of the shares sold from $77.12 to $77.38 per share.
- The shares underlying this option vested and became exercisable in 12 equal monthly installments, with the first installment on July 16, 2016.
- The shares underlying this option vested and became exercisable in 12 equal monthly installments, with the first installment on July 20, 2017.
Billionaire Hedge Funds
